DCM
BIIB icon

DGS Capital Management’s Biogen BIIB Stock Holding History

DGS Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$529K Buy
2,886
+704
+32% +$130K 0.09% 222
2025
Q4 		$384K Buy
2,182
+474
+28% +$77.4K 0.07% 259
2025
Q3 		$239K Buy
+1,708
New +$231K 0.04% 345
2024
Q1 		– Sell
-1,265
Closed -$327K – 298
2023
Q4 		$327K Buy
1,265
+51
+4% +$12.5K 0.13% 154
2023
Q3 		$312K Sell
1,214
-170
-12% -$45.5K 0.15% 145
2023
Q2 		$394K Buy
1,384
+48
+4% +$14.3K 0.2% 119
2023
Q1 		$371K Sell
1,336
-352
-21% -$97.4K 0.21% 115
2022
Q4 		$467K Buy
1,688
+711
+73% +$201K 0.31% 79
2022
Q3 		$261K Buy
+977
New +$207K 0.17% 133

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DGS Capital Management's BIIB Position: Q1 2026 in Review

DGS Capital Management increased its Biogen (BIIB) stake by 32% in Q1 2026, buying an estimated $130K and bringing the position to 2,886 shares worth $529K. The position accounts for 0.09% of the portfolio, ranked #222.

DGS Capital Management first reported a position in BIIB in Q3 2022 and has held it in 9 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • DGS Capital Management held 2,886 shares of Biogen worth $529K as of Q1 2026.
  • DGS Capital Management bought 704 Biogen shares in Q1 2026, an estimated $130K.
  • Biogen made up 0.09% of DGS Capital Management's portfolio in Q1 2026, its #222 holding.
  • DGS Capital Management first reported a position in Biogen in Q3 2022 and has held it in 9 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.